Registry on Monitoring the Effectiveness and Tolerability of Basal (Plus/Bolus) Regimen with LantusÒ (Insulin Glargine) and ApidraÒ (Insulin Glulisine) in T2 Diabetes Mellitus Patients in Everyday Practice in Saudi
2020-07-04
عنوان الدراسة
Registry on Monitoring the Effectiveness and Tolerability of Basal (Plus/Bolus) Regimen with LantusÒ (Insulin Glargine) and ApidraÒ (Insulin Glulisine) in T2 Diabetes Mellitus Patients in Everyday Practice in Saudi
داعم الدراسة
Sanofi
دواء الدراسة
Lantus®
رقم بروتوكول الدراسة
LANTUL06939
حالة الدراسة
Ongoing
موقع الدراسة
King Fahd Military Medical Complex (Dhahran), Armed Forces Hospital (Southern Region), Polyclinics in western province
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。